首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Aortic remodeling in type B aortic dissection: effects of endovascular stent-graft repair and medical treatment on true and false lumen volumes.
【24h】

Aortic remodeling in type B aortic dissection: effects of endovascular stent-graft repair and medical treatment on true and false lumen volumes.

机译:B型主动脉夹层中的主动脉重塑:血管内覆膜支架修复和药物治疗对真假管腔容积的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To analyze aortic remodeling processes in terms of true (TL) and false lumen (FL) volumes in patients with type B aortic dissection undergoing thoracic endovascular aortic repair (TEVAR) versus patients treated medically. METHODS: Serial contrast-enhanced computed tomography (CT) scans of 27 type B dissection patients (24 men; mean age 60+/-13 years) who underwent TEVAR (n = 17) or medical therapy only (n = 10) were analyzed. TL and FL volumes over the entire descending aorta at baseline and at follow-up were quantified by 3-dimensional reconstruction. RESULTS: Follow-up in the 27 patients was a mean 14+/-6 months. TEVAR resulted in a continued gain in total TL volume (132+/-56 mL at baseline, 164+/-51 mL early after TEVAR, and 220+/-68 mL at follow-up, p<0.001), whereas TL volume was almost unchanged in the medical therapy group (113+/-34 to 120+/-41 mL, p = 0.195). Total FL volume decreased significantly in TEVAR patients during follow-up (257+/-147 mL at baseline to 178+/-140 mL, p<0.001), whereas there was no significant change in FL volume in the medical therapy patients. The increase of TL and the decrease of FL volume in the TEVAR group were mainly observed in the descending thoracic aorta. CONCLUSION: TEVAR for type B aortic dissection results in a significant increase in TL and a decrease in FL volumes, not only acutely but also over time due to continued remodeling processes primarily in the thoracic aorta, with little impact on abdominal aortic volumes. Our data provide insight into the mechanism of a potential therapeutic benefit of TEVAR over medical therapy in type B dissection, which remains to be confirmed in a randomized clinical trial.
机译:目的:以接受胸腔内血管主动脉修复术(TEVAR)的B型主动脉夹层患者和接受药物治疗的B型主动脉夹层患者的真实(TL)和假管腔(FL)容积来分析主动脉重构过程。方法:分析了27例行TEVAR(n = 17)或仅接受药物治疗(n = 10)的B型清扫术患者(24名男性;平均年龄60 +/- 13岁)的对比增强计算机断层扫描(CT)扫描。 。通过三维重建对基线和随访时整个降主动脉的TL和FL体积进行定量。结果:27例患者的平均随访时间为14 +/- 6个月。 TEVAR导致总TL体积持续增加(基线时为132 +/- 56 mL,TEVAR早期为164 +/- 51 mL,随访时为220 +/- 68 mL,p <0.001),而TL体积在药物治疗组中几乎没有变化(113 +/- 34至120 +/- 41 mL,p = 0.195)。在随访期间,TEVAR患者的总FL量显着降低(基线时为257 +/- 147 mL,至178 +/- 140 mL,p <0.001),而药物治疗患者的FL量没有显着变化。 TEVAR组TL的增加和FL体积的减少主要在胸主动脉下降中观察到。结论:TEVAR用于B型主动脉夹层术不仅导致急性期而且随着时间的推移,由于主要在胸主动脉中的持续重塑过程,导致TL显着增加和FL容量减少,而对腹主动脉容积影响不大。我们的数据提供了对TEVAR优于B型解剖的药物治疗的潜在疗效机制的见解,这仍有待于随机临床试验中证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号